MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience

被引：9

作者：

Rauch, Aymeric ^{[1
]}

Cazzato, Roberto Luigi ^{[1
]}

Garnon, Julien ^{[1
]}

Shaygi, Behnam ^{[2
]}

Tsoumakidou, Georgia ^{[1
]}

Caudrelier, Jean ^{[1
]}

Bauones, Salem ^{[1
]}

Koch, Guillaume ^{[1
]}

Lipsker, Dan ^{[3
]}

Gangi, Afshin ^{[1
]}

机构：

[1] Hop Univ Strasbourg, Nouvel Hop Civil, Intervent Radiol Dept, 1 Pl Hop, F-67000 Strasbourg, France

[2] Royal Devon & Exeter Hosp, NHS Trust, Intervent Radiol Dept, Barrack Rd, Exeter EX2 5DW, Devon, England

[3] Hop Univ Strasbourg, Dermatol Dept, 1 Pl Hop, F-67000 Strasbourg, France

来源：

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 2017年 / 40卷 / 08期

关键词：

In-transit metastases; Melanoma; Cryoablation; MRI; MANAGEMENT; THERAPY;

D O I：

10.1007/s00270-017-1645-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study aims to discuss MRI-guided cryoablation (CA) of in-transit (IT) metastases from melanoma and to retrospectively present our preliminary experience in such a specific field. Three female patients (mean age 55.6 years; range 39-64) were included, and eight IT metastases (mean size 12.4 +/- 6.5 mm, range: 5-25) were treated in three different sessions. Technical success was 100%; and mean procedural time 129.3 +/- 103 min. (range 42-243). Primary local tumour control was 100% at 1-, 6- and 12-month follow-up; and 87.5% at 18-month follow-up. Two complications were recorded (one minor and one major). MRI-guided CA is a novel therapy, which may be included in the armamentarium of local therapies of IT metastases.

引用

页码：1285 / 1289

页数：5

共 9 条

[1]

Balch C.M., 2010, AM JOINT COMMITTEE C, V7th, P325

[2] Percutaneous image-guided cryoablation: current applications and results in the oncologic field [J].